|
|
|
Insider
Information: |
Granadillo Pedro P |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
258,751 |
|
Indirect Shares
|
118,154 |
|
|
Direct
Value |
$99,550,272 |
|
|
Indirect Value
|
$90,736,502 |
|
|
Total
Shares |
376,905 |
|
|
Total
Value |
$190,286,774 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
First Indiana Corp |
FINB |
Director |
2008-01-02 |
0 |
2004-01-02 |
0 |
Premium* |
|
Haemonetics Corp |
HAE |
Director |
2018-11-08 |
15,335 |
2005-09-02 |
0 |
Premium* |
|
Capricor Therapeutics |
CAPR |
Director |
2007-10-16 |
27,588 |
|
0 |
Premium* |
|
Eli Lilly & Co |
LLY |
Senior Vice President |
2004-09-23 |
106,316 |
2004-09-23 |
98,154 |
Premium* |
|
Dendreon Corp |
DNDN |
Director |
2014-01-03 |
87,251 |
2009-10-07 |
0 |
Premium* |
|
NPS Pharmaceuticals Inc |
NPSP |
Director |
2015-02-21 |
0 |
2013-02-07 |
0 |
Premium* |
|
Immunovant Inc |
IMVT |
Director |
|
0 |
2019-05-09 |
20,000 |
Premium* |
|
Orchestra BioMed Holdings Inc. |
OBIO |
Director |
2020-08-03 |
22,261 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HAE |
Haemonetics Corp |
Director |
|
2011-08-15 |
4 |
S |
$59.74 |
$50,779 |
D/D |
(850) |
5,595 |
0 |
- |
|
DNDN |
Dendreon Corp |
Director |
|
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
37,251 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2012-07-27 |
4 |
A |
$0.01 |
$10 |
D/D |
1,031 |
6,626 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2012-08-13 |
4 |
OE |
$44.74 |
$268,440 |
D/D |
6,000 |
12,626 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2012-08-13 |
4 |
S |
$70.05 |
$420,310 |
D/D |
(6,000) |
6,626 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2012-11-12 |
4 |
OE |
$29.90 |
$615,510 |
D/D |
16,000 |
16,626 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2012-11-12 |
4 |
S |
$80.40 |
$1,286,341 |
D/D |
(16,000) |
6,626 |
0 |
- |
|
DNDN |
Dendreon Corp |
Director |
|
2013-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
62,251 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
Director |
|
2013-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
15,225 |
15,225 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2013-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,649 |
14,901 |
0 |
- |
|
DNDN |
Dendreon Corp |
Director |
|
2014-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
87,251 |
0 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
Director |
|
2014-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,188 |
30,413 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2014-03-10 |
4 |
AS |
$36.70 |
$214,184 |
D/D |
(5,836) |
14,901 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2014-03-10 |
4 |
OE |
$14.95 |
$105,617 |
D/D |
5,836 |
18,901 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2014-04-07 |
4 |
OE |
$14.95 |
$105,642 |
D/D |
5,837 |
18,901 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2014-04-07 |
4 |
AS |
$31.98 |
$186,680 |
D/D |
(5,837) |
14,901 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2014-05-07 |
4 |
OE |
$14.95 |
$105,642 |
D/D |
5,837 |
18,901 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2014-05-07 |
4 |
AS |
$31.14 |
$181,780 |
D/D |
(5,837) |
14,901 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2014-06-06 |
4 |
OE |
$14.95 |
$105,642 |
D/D |
5,837 |
18,901 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2014-06-06 |
4 |
AS |
$34.69 |
$202,499 |
D/D |
(5,837) |
14,901 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2014-07-07 |
4 |
AS |
$35.90 |
$209,978 |
D/D |
(5,837) |
14,901 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2014-07-07 |
4 |
OE |
$14.95 |
$105,642 |
D/D |
5,837 |
18,901 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2014-07-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,394 |
17,295 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2015-02-18 |
4 |
OE |
$29.23 |
$331,117 |
D/D |
11,328 |
28,623 |
0 |
- |
|
HAE |
Haemonetics Corp |
Director |
|
2015-02-18 |
4 |
S |
$43.45 |
$492,161 |
D/D |
(11,328) |
17,295 |
0 |
- |
|
62 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|